￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Phase III clinical trial of dacomitinib in the treatment of locally advanced or metastatic non-small cell lung cancer carrying EGFR_ Kanghule

2025-10-19 11:44:20

Check Details
What are the differences between the second-generation targeted drug for lung cancer, dacomitinib, and the first-generation drug?

2025-10-19 11:44:20

Check Details
Effects and effects of crizotinib (Xalkori) on ROS1 mutated lung cancer

2025-10-19 11:44:20

Check Details
Cabozantinib (XL184) is a potent ROS1 inhibitor_ Kangxi

2025-10-19 11:44:20

Check Details
How about crizotinib (Xalkori) in treating lung cancer?

2025-10-19 11:44:20

Check Details
Does the targeted drug vandetanib have an effect on patients with RET mutations in lung cancer?

2025-10-19 11:44:20

Check Details
Which patients with lung cancer can vandetanib be used to treat?

2025-10-19 11:44:20

Check Details
Ramucirumab + docetaxel for metastatic non-small cell lung cancer that worsens during or after platinum-containing chemotherapy_ Kanghule

2025-10-19 11:44:20

Check Details
How much does a box of Vandetanib cost? Where can I buy it in China?

2025-10-19 11:44:20

Check Details
The effect and toxic side effects of vandetanib in the treatment of lung cancer with specific gene mutations

2025-10-19 11:44:20

Check Details
Data on ramucirumab in the treatment of metastatic non-small cell lung cancer with EGFR gene mutations

2025-10-19 11:44:20

Check Details
Vandetanib can effectively improve the median progression-free survival of lung cancer with specific gene mutations

2025-10-19 11:44:20

Check Details
Category
相关知识